当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析

复星医药

(600196)

  

流通市值:524.11亿  总市值:660.66亿
流通股本:21.18亿   总股本:26.70亿

复星医药(600196)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润9.42亿元,每股收益0.29元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益6084990.19万元,未分配利润2731781.64万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产11799048.89万元,负债5714058.70万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入9,420,322,797.3441,067,195,862.5930,911,889,002.920,462,812,731.15
营业总成本9,130,342,151.6839,397,511,520.6429,362,812,762.8519,408,879,676.26
营业利润1,358,771,228.344,245,103,909.313,107,588,817.821,929,286,791.65
利润总额1,347,541,972.014,169,281,679.723,071,565,885.41,931,200,793.34
净利润941,566,276.853,512,440,3852,518,517,637.461,549,731,977.11
其他综合收益-110,471,546.9543,142,250.33-213,927,299.31112,419,919.18
综合收益总额831,094,729.93,555,582,635.332,304,590,338.151,662,151,896.29
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计34,438,609,708.9334,491,060,582.7334,527,299,352.0534,797,913,650.75
非流动资产合计83,551,879,181.1682,969,506,766.5480,737,462,405.0980,739,900,515.14
资产总计117,990,488,890.09117,460,567,349.27115,264,761,757.14115,537,814,165.89
流动负债合计35,500,536,915.2537,452,669,252.7937,517,582,094.3737,401,861,771.44
非流动负债合计21,640,050,046.7620,074,169,184.1618,552,575,493.1419,274,010,769.39
负债合计57,140,586,962.0157,526,838,436.9556,070,157,587.5156,675,872,540.83
归属于母公司股东权益合计47,923,631,569.9547,261,106,860.7347,301,473,095.2446,967,200,004.14
股东权益合计60,849,901,928.0859,933,728,912.3259,194,604,169.6358,861,941,625.06
负债和股东权益合计117,990,488,890.09117,460,567,349.27115,264,761,757.14115,537,814,165.89
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计10,431,224,855.4743,172,147,821.7731,551,927,328.3920,745,072,818.22
经营活动现金流出小计9,375,544,977.0238,695,166,559.5528,565,289,973.2218,838,068,920.22
经营活动产生的现金流量净额1,055,679,878.454,476,981,262.222,986,637,355.171,907,003,898
投资活动现金流入小计1,275,324,161.382,405,322,190.851,823,762,368.12516,001,223.51
投资活动现金流出小计1,460,415,546.786,018,645,562.074,263,474,836.993,165,950,137.69
投资活动产生的现金流量净额-185,091,385.4-3,613,323,371.22-2,439,712,468.87-2,649,948,914.18
筹资活动现金流入小计6,711,769,738.5833,369,274,946.323,965,139,058.3117,913,255,802.79
筹资活动现金流出小计7,345,397,027.4234,371,861,283.6624,467,428,47116,822,691,626.93
筹资活动产生的现金流量净额-633,627,288.84-1,002,586,337.36-502,289,412.691,090,564,175.86
汇率变动对现金及现金等价物的影响8,912,313.0327,989,327.43-69,635,970.1417,131,450.21
现金及现金等价物净增加额245,873,517.24-110,939,118.93-25,000,496.53364,750,609.89
期末现金及现金等价物余额9,637,323,304.359,391,449,787.119,477,388,409.519,867,139,515.93
最新报告期:2025-05-14
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
浙商证券郭双喜1.221.371.572025-05-14
中金公司俞波,张琎1.301.56--2025-04-30
中信证券陈竹,韩世通1.181.361.622025-04-08
中金公司俞波,张琎1.301.56--2025-03-31
TOP↑